OSE Immunotherapeutics Presents Positive Step-1 Phase 3 Results for Tedopi® in NSCLC at the European Society for Medical Oncology Virtual Congress 2020

NEXT STORY
Immunicum AB: Invitation to Corporate Update Event
PREV STORY
iCAD Responds to CMS’ Finalized Radiation Oncology Alternative Payment Model
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

The Obesity Society Updates Position on Obesity

author_avatar
NASDAQ Market News

Sanofi’s virtual R&D Day event to highlight capabilities, platforms, and expertise in disease pathways to deliver potentially transformative treatments to patients

author_avatar
NASDAQ Market News

Sanofi and Ablynx Announce the Successful Results of the Initial Tender Offer Period for Ablynx and Commencement of Squeeze-Out Tender Period

  Press ReleaseSource: Sanofi (EURONEXT: SAN) (NYSE: SNY)  Sanofi and Ablynx Announce the Successful ...

author_avatar
NASDAQ Market News